05 June 2018 1 Min Read
Submissions are now open to acquire a majority shareholding in Synexa Life Sciences
Clinical research companies are invited to apply to acquire a majority shareholding in a specialist biomarker services provider
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In